MIM
VECT

Monashee Investment Management’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Monashee Investment Management’s Portfolio VECT Stock Details VECT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-54,466
Closed -$635K – 427
2021
Q2 		$635K Buy
+54,466
New +$827K 0.08% 227

Other funds holding VECT

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.36B AUM 21.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Monashee Investment Management's VECT Position: Q3 2021 in Review

Monashee Investment Management sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q3 2021, closing a stake of 54,466 shares — an estimated $635K sold.

Monashee Investment Management first reported a position in VECT in Q2 2021 and held it in 1 quarter. The position peaked at $635K in Q2 2021. 25 funds tracked by Wall St. Rank hold VECT as of Q3 2021.

  • Monashee Investment Management reported no remaining VectivBio Holding AG Ordinary Shares position as of Q3 2021 after selling out during the quarter.
  • Monashee Investment Management sold 54,466 VectivBio Holding AG Ordinary Shares shares in Q3 2021, an estimated $635K.
  • Monashee Investment Management first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2021 and held it in 1 quarter.
  • Monashee Investment Management's VectivBio Holding AG Ordinary Shares position peaked at $635K in Q2 2021.
  • 25 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q3 2021.

Based on Monashee Investment Management's 13F filing for Q3 2021, filed 9 Nov 2021.